KALA (STOCKS)
KALA BIO, Inc. Common Stock
$2.600000
-0.030000 (-1.14%)
Prev close: $2.630000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Avi Minkowitz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $49.63M
- Employees
- 38
- P/E (TTM)
- -0.02
- P/B (TTM)
- 4.54
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-33.50 | $-73.44 | +39.9400 | +54.38% |
|
Sep 2025 (Q3)
|
$-43.00 | $-73.72 | +30.7205 | +41.67% |
|
Jun 2025 (Q2)
|
$-85.50 | $-86.87 | +1.3698 | +1.58% |
|
Mar 2025 (Q1)
|
$-70.50 | $-103.53 | +33.0300 | +31.90% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $10.64M |
| Operating Expenses | $30.29M |
| Operating Income/Loss | -$30.29M |
| Income/Loss From Continuing Operations After Tax | -$19.65M |
| Income/Loss From Continuing Operations Before Tax | -$19.65M |
| Net Income/Loss | -$19.65M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.65M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.65M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.06 |
| Diluted Earnings Per Share | -$2.06 |
| Basic Average Shares | 26,941,045 |
| Diluted Average Shares | 26,941,045 |
| Assets | $12.32M |
| Current Assets | $12.32M |
| Noncurrent Assets | $0.00 |
| Liabilities | $1.56M |
| Current Liabilities | $1.56M |
| Accounts Payable | $1.04M |
| Wages | $5.00K |
| Other Current Liabilities | $508.00K |
| Noncurrent Liabilities | $0.00 |
| Equity | $10.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $10.76M |
| Liabilities And Equity | $12.32M |
| Net Cash Flow From Operating Activities | -$34.89M |
| Net Cash Flow From Operating Activities, Continuing | -$34.89M |
| Net Cash Flow From Investing Activities | -$15.97M |
| Net Cash Flow From Investing Activities, Continuing | -$15.97M |
| Net Cash Flow From Financing Activities | -$7.38M |
| Net Cash Flow From Financing Activities, Continuing | -$7.38M |
| Net Cash Flow | -$46.74M |
| Net Cash Flow, Continuing | -$46.74M |
| Comprehensive Income/Loss | -$19.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.65M |
| Other Comprehensive Income/Loss | -$18.72M |